Vima Therapeutics website homepage promoting innovative treatments for dystonia and other movement disorders, shown in desktop and mobile layouts.

October 2025-March 2026

Vima Therapeutics: Product launch site

❋ Project Highlights

  • Delivered Vima’s launch website on a compressed Oct–Dec schedule and met time‑sensitive product and investor milestones

  • Went live before Vima announced an expanded Series A, growing the company’s from $60M to $100M

❋ The Challenge

Vima had a barebones landing page, but now needed a credible site to help secure Series A funding. They needed to clearly convey the patient journey, the science behind the approach, and the company’s milestones, to better understand the disease, the need for new therapies, and how Vima’s work could translate into real-world movement improvement.

Translate complex neuroscience and clinical strategy into an accessible experience in time for critical investor and public milestones.


I adopted a cohesive, user-centered UI/UX framework built on clarity, accessibility, and scalability to guide users from understanding dystonia to learning about Vima’s approach and then to actionable next steps (clinical study enrollment, press, or contact).

❋ My Solution 

Supporting the agency IQVIA, I led the UX and UI overhaul of the site to create a clear, patient-centered narrative and a scalable, investor-friendly experience. I collaborated closely with Art Directors to align illustration style, iconography, and user experience with the brand voice. I also worked with a team of talented copywriters, project managers, developers, and client services to help bring this project to life.

The updated home page and supporting sections delivered a more confident, credible portrayal of Vima’s mission and progress. Overall, the new design elevates brand credibility and significantly improves accessibility and usability (especially for people with dystonia) without sacrificing the friendly, human tone of the Vima brand. The visual language leverages calm blues and soft rounded shapes to convey trust and approachability, with modular content blocks that adapt across desktop and mobile.

❋ Key Responsibilities

UX/UI, responsive design, developer handoff, client presentation

❋ Deliverables

High fidelity mockups & prototypes, asset library repository, style guide & documentation

❋  Live Links
Side-by-side Vima Therapeutics website designs promoting dystonia and movement disorder treatments, patient stories, research, and company information.

Home Page Before & After

❋ Before (left)
barebones and hard to grasp the dystonia narrative

❋ After (right)
patient-focused, structured, and clear calls to action

A bold but approachable layout with visually distinct sections that highlight the Stride study, patient stories, and the Vima team. The hero conveys movement and hope, while the supporting blocks concisely present the disease context and calls to action.

The approach also emphasizes transparency about milestones (e.g., Series A funding, mid-stage readouts) and supports diverse audiences—patients, clinicians, journalists, and potential partners—through consistent navigation, readable copy, and prominent CTAs. Considerations included:

  • larger, high-contrast buttons for accessibility

  • easy-to-read card patterns for resources and news

  • simple page layouts that reduce cognitive load

Screenshot of the Vima website homepage promoting movement disorder research and dystonia patient resources

User Experience: Prioritizing accessibility for patients with movement disorders

Throughout the project I advocated for accessibility considerations. I proposed larger buttons, generous line spacing, and bigger body text to support users with dystonia who may experience involuntary movements.

I also established clear, scannable sections with strong headings and descriptive CTAs so visitors could find clinical study details, resources, and company information with minimal effort.

This is an early prototype of the UX phase, where we were still figuring out messaging, claims, and even possible indications.